Introduction
Epidemiological studies have shown a high prevalence of tricuspid regurgitation (TR) in the general population 1 and particularly in patients with left-sided heart disease 2 or pulmonary hypertension (PH). 3 Secondary or functional TR (FTR), the most frequent form of TR, occurs in 70-85% of patients. FTR is characterized by structurally normal tricuspid leaflets and caused by tricuspid annular dilatation and increased tricuspid leaflet tethering due to right ventricular (RV) remodelling, which is often due to left heart failure (HF) from myocardial or valvular causes and associated PH. [4] [5] [6] Two major risk factors for FTR progression have been described; an increase in pulmonary artery systolic pressure (PASP) and atrial fibrillation (AF). 7 Increase in PASP may lead to RV remodelling (both increase in volumes and change in geometry), which in turn leads to tricuspid valve (TV) leaflets tethering, 4, 8, 9 whereas AF promotes atrial dilatation, which in turn lead to TV annular dilatation and remodelling. The prognostic role of TR associated with organic left-sided valvular heart disease is well known. [10] [11] [12] However, the value of FTR in outcome stratification and the incremental prognostic significance of FTR in patients with HF are less clear. This is particularly true in patients with overt HF, 2 where multiple coexisting comorbidities interact with the effect of FTR. Indeed, the complex relationship between FTR and PH and RV function is likely to affect the final clinical outcome, suggesting that these associated prognostic determinants of HF might explain the increased mortality associated with TR. Therefore, we sought to study the prognostic implications and clinical correlates of FTR in patients with acute decompensated HF (ADHF).
Methods
Between January 2008 and April 2015, all patients admitted to the Rambam Medical Center, Haifa, Israel with the primary diagnosis of ADHF entered a prospective registry. 13 Eligible patients were those hospitalized with new-onset or worsening of pre-existing HF as the primary cause of admission. ADHF was diagnosed according to the European Society of Cardiology criteria including a brain natriuretic peptide (BNP) level > 400 pg/mL. The study was performed in accordance with the Declaration of Helsinki and approved by the institutional review committee on human research.
Congestion score
Assessment of congestion at hospital admission was done by the treating physician. The degree of congestion was evaluated based on a combination of several signs and symptoms as previously described. 14 A composite congestion score was calculated by summing the individual scores at the time of admission and discharge (range 0-8).
Echocardiographic evaluation
All patients had an echocardiographic examination performed during hospital stay or within a period of 30 days prior or after the day of admission [median 2 days, interquartile range (IQR) 1-4 days]. PASP was estimated from clearly defined TR signal by continuous-wave Doppler and inferior vena cava size and respiratory variation using established criteria, as previously described. 15 PH was defined using the cut-off of PASP > _ 50 mmHg.
13
TR was quantified by an integrated approach. 3 First, TR was graded qualitatively using color Doppler flow mapping as follows: trivial TR (jet area < _1.0 cm . 8 When more than mild TR was present, severity was determined by integrating data from the following parameters: TV morphology (flail/large coaptation defect); vena contracta width when feasible (> _7 mm denoting severe TR); presence and degree of malcoaptation of the TV leaflets; tenting distance; presence of mid-to-late systolic flow reversal in the hepatic veins, and evaluation of right heart chambers. 1, 3, 8, 15 RV function was assessed qualitatively by integrating visual assessment of the contractility of the RV walls from different views and classified on an ordinal scale (normal or mildly, moderately, or severely reduced) and quantitatively by calculating the RV fractional area change, with a value <35% defined as abnormal, as previously described. 5, 13, 16 RV dysfunction was considered to be present if at least mild systolic dysfunction was observed. The agreement in the assessment of RV function between echo readers was high (Cohen's Kappa 0.82, 95% CI 0.67-0.97).
To determine whether the type of FTR affects clinical outcome, patient with moderate or severe FTR were further divided into two subgroups based on the presence or absence of PH. Patients with PASP < 50 mmHg were labelled as non-PH related FTR (non-PH FTR) and patients with PASP > _ 50 mm Hg as PH-FTR.
Study endpoint
The primary endpoint of the study was the composite of readmission for HF and mortality after hospital discharge. Following hospital discharge, clinical endpoint information was acquired by reviewing the national death registry and by reviewing the hospital records for major clinical events if the patient had been re-hospitalized.
Statistical analysis
Continuous variables are presented as mean ± standard deviation (SD) or medians (with IQR), and categorical variables as numbers and percentages. Baseline characteristics of the groups were compared using analysis of variance (ANOVA) for continuous variables and by the v 2 statistic for non-continuous variables. The association between moderate or severe TR and other echocardiographic or clinical parameters was determined by fitting logistic regression model. Odds ratios were calculated with their 95% confidence intervals (CIs), and the relative strength of the associations was expressed by the standardized coefficient to compare effect estimates.
Survival curves were constructed for the TR categories using the Kaplan-Meier method. Stepwise Cox proportional hazards models with backward selection were used to calculate hazard ratios (HRs) and 95% CI for the TR categories. The multivariable Cox regression was adjusted for clinical, laboratory, and echocardiographic variables listed in Table 1 and the congestion score.
Survival analyses were also performed to determine whether the type of FTR affects clinical outcome beyond TR severity. Because in previous studies 2 and the present study the outcome of patients with trivial and mild TR was similar and moderate and severe TR was also similar, these TR categories were combined into two groups (trivial/mild and moderate/severe TR) and further classified into those with or without PH. The existence of an interaction between TR severity and PH was assessed using a Cox proportional hazards regression model incorporating terms for the main effect of TR severity, the main effect of PH, and the interaction between TR severity and PH.
Because the echocardiographic and clinical characteristics of patients with trivial/mild TR differed markedly from those with moderate/severe TR, propensity score estimates representing the probability of a patient being in the moderate/severe TR were generated using a non-parsimonious multiple logistic regression model derived from echocardiographic and clinical variables. Following propensity score generation, patients were matched by using 1:1 nearest neighbour (Greedy-type) matching without replacement and a calliper width of a 0.2 SD of the propensity score logit.
We assessed the success of the matches by examining standardized differences (measured in percentage points) in the observed confounders between the matched trivial/mild TR and moderate/severe TR groups. Small (<10%) standardized differences support the assumption of balance between groups based on observed confounders. Following the matching procedure, Cox proportional hazards model accounting for frailty effects within matched pairs (to account for dependence among matched subjects) was used to assess the risk of the primary endpoint for patients with trivial/mild FTR vs. moderate/severe FTR. Differences were considered statistically significant at the two-sided P < 0.05 level. Statistical analyses were performed using STATA Version 13.1 (College Station, TX, USA).
Results
During the study period, 709 patients who met the inclusion criteria were recruited. Moderate or severe TR was observed in 242 patients (34%) and trivial or mild TR in 467 patients (66%). PASP could be estimated in 639 patients (90%). Demographic and clinical characteristics of the 709 patients with TR data are shown in Table 1 pressures. Compared with patients with moderate TR, patients with severe TR had higher annular dimensions, higher tenting area, and tenting height.
Increasing TR severity was associated with higher BNP levels ( Figure 1A ) and among the liver function tests, c-glutamyl transferase, and alkaline phosphatase increased with increasing TR grade ( Figure  1B ). There was a graded increase in the congestion score at admission with increasing TR severity ( Figure 1C ).
In the 639 (90%) patients with estimable PASP, there was a graded increase in PASP with increasing TR grade, albeit with large overlap ( Figure 1D ). The median PASP was 55 and 60 mmHg in patients with moderate and severe TR, respectively. In multivariable logistic regression analyses, PASP, RV dysfunction, moderate or severe MR, AF, hyponatremia, and blood urea nitrogen were independently associated with moderate or severe TR ( Table 2) . The c-statistic of the model was 0.81 (95% CI 0.77-0.84), indicating excellent discrimination. By multivariate analysis, PASP was most closely related to moderate or severe TR, with a standardized coefficient higher than RV dysfunction or AF ( 
Effect of TR on mortality and rehospitalization
Patients were followed for up to 2 years after hospital discharge (median 19 months). During the follow-up period, 242 patients (34.1%) died and 174 (24.5%) were readmitted for HF. The KaplanMeier survival curves demonstrated similar outcome for patients with trivial or mild TR and for patients with moderate or severe TR ( Figure 3) . Further analyses therefore compared the effect of moderate and severe TR to mild and trivial TR. Table 3 (left panel) displays univariable predictors of readmission for HF and mortality. In the unadjusted analysis, moderate or severe TR was associated with the composite endpoint. However, after adjustments for baseline clinical characteristics, laboratory and echocardiographic variables, moderate or severe TR was no longer an independent predictor of readmission for HF and mortality ( Table 3 , right panel).
To determine whether loading conditions may have confounded the study results (i.e. patients who were more congested were misclassified into the moderate or severe TR group), we tested whether the effect of TR on clinical outcomes varied with the time of TR assessment. This was done by comparing the effect of TR in patients in whom the echocardiographic evaluation was performed within 3 days from admission vs. patients with echocardiographic evaluation >3 days from admission.
The proportion of moderate or severe TR was similar with echocardiographic assessment within or >3 days from admission (37.8 vs. 36.7%, P = 0.80). There was no interaction between the time of TR assessment and TR severity with regard to the risk of rehospitalization for HF or mortality (P interaction =0.34). In a stratified sensitivity analysis that included the 348 patients in whom the echocardiographic evaluation of TR severity was performed during the first 3 days after admission, results were comparable with the primary analyses, with similar strength of the predictors. Moderate or severe TR was not significantly associated with readmission for HF and mortality (HR 1.16, 95% CI 0.83-1.64, P = 0.38), whereas PASP (HR 1.18 per 1 SD increase in ln PASP; 95% CI 1.02-1.38, P = 0.028) remained significantly associated with readmission for HF and mortality. Similar results were seen in the subset of patients in whom the echocardiographic evaluation of TR severity was performed more than 3 days from admission (n = 291). Moderate or severe TR was not associated with clinical outcome (HR 1.17, 95% CI 0.81-1.69, P = 0.39), whereas PASP predicted increased readmission for HF and mortality (HR 1.21 per 1 SD increase in ln PASP; 95% CI 1.03-1.42, P = 0.021).
Impact of concomitant PH on the association between FTR and clinical outcome
Of the 639 patients with estimable PASP, 239 had moderate or severe TR, with 68 having no PH-associated TR (28%) and 171 having PH-FTR (72%). There was no significant difference between the two groups with regard to annular 4-Chamber diastolic diameter (4.0 ± 0.7 vs. 3.9 ± 0.6, P = 0.39), annular-4C systolic diameter (3.8 ± 0.6 vs. 3.7 ± 0.5, P = 0.71), tenting area (1.84 ± 1.23 vs. 1.57 ± 1.03, P = 0.11), and tenting height (0.86 ± 0.44 vs. 0.80 ± 0.40, P = 0.37).
The clinical outcome of these two groups was compared with patient having trivial/mild TR with and without PH. Unadjusted rates of readmissions for HF and mortality in the four groups are shown in Figure 4 . Event rates were lowest in patients without significant TR and without PH. There was a marked increase in the risk of HF or mortality in patients with both moderate-severe TR and PH, while patients with mild TR and PH had an intermediate risk. patients with moderate-severe TR but no PH were also at intermediate risk for readmission and mortality. In a Cox proportional hazards regression analysis, there was a significant interaction between TR severity and PH (P interaction = 0.03), such that after adjustments for other risk variables (Table 4) , patients with moderate-severe TR without PH had similar outcome to that of patients with trivial/mild TR. The risk associated with moderatesevere TR appeared to be driven primarily by the presence of concomitant PH.
Propensity score matching
One-to-one matching on the propensity score yielded only 26 patient pairs. Before matching the standardized difference was highest for the PASP and RV function variables ( Figure 5A ). After propensity score matching, patients were well balanced with respect to the variables included in the propensity model ( Figure 5A) , with mean difference in paired propensity scores of 3.2%. Following propensity score matching, readmissions for HF and mortality were similar in patients with moderate/severe TR and trivial/mild TR ( Figure 5B ) with a HR of 1.0 (95% CI 0.49-2.06, P = 0.99).
Discussion
In the present study, we observed a high prevalence of haemodynamically significant TR in patients with acute HF. TR severity was associated with multiple clinical comorbidities and risk markers including worse renal function, higher BNP levels and congestion score, as well as with mitral regurgitation, AF, RV dysfunction, reduced LVEF, and PH. After careful adjustments for the associated clinical and echocardiographic variables, significant TR (moderate or severe) was associated with higher multivariable adjusted risk for readmission for HF or mortality only in the presence of concomitant PH.
Previous studies described a strong impact of TR on clinical outcome in the settings of valvular heart disease especially after mitral valve intervention, 10, 12 and in isolated TR. 17 However, only a paucity of studies with contradictory results are currently available with regard to the prognostic significance of TR in the setting of overt HF. Two studies reported increased mortality in patients with moderate and severe TR. 18, 19 However, in both studies TR was not considered along with other known predictors of survival like PH. In addition, these studies lacked information on symptoms, biomarkers, and kidney function. In a more recent study, Neuhold et al. 2 reported that the prognostic impact of FTR in chronic HF was significantly associated with excess mortality only in mildly or moderately reduced LV function with no additive value in more advanced disease. In contrast to these previous studies, our study population was confined to patients with symptomatic HF requiring hospitalization.
There is an inherent difficulty to determine the haemodynamic consequences and clinical outcome of TR due to multiple associated comorbidities, especially in the setting of HF. In the present study, only 7% of the patients with moderate or severe TR were free of other important cardiac abnormalities (MR, reduced LVEF, PH, or RV dysfunction). Propensity matching procedure could match <10% of patients owing to the marked baseline differences. Although the small number of matched patients precludes us from drawing conclusions from this analysis, it demonstrates the pitfalls of comparing patients with moderate/severe TR to those with trivial/mild TR. The strong relationship between increasing TR severity and important cardiac comorbidities, contributes to the current uncertainties regarding the clinical significance and surgical management of TR, especially in the presence of severe RV or LV dysfunction, or severe PH. 20 Two major forms of FTR have recently been proposed: (i) FTR that is strongly associated with aging and AF. 4, 7 This variant appears to result predominantly from annular enlargement leading to exhaustion of annular coverage reserve. 4 (ii) PH-associated FTR which entails mainly valvular tethering with tenting and reduced coaptation, 4 but can also be associated with annular dilatation 6 which further contributes to increased tenting area. In the present study of patients with overt HF, there was a large overlap in annular size and tenting parameters between patients with and without PH, 21 and because annular dilatation can also be associated with PH. 6 Although PH is not a necessary prerequisite for the development of secondary TR, 1 it remains a major mechanism for TR progression, especially in patients with HF, in whom pulmonary pressure is frequently elevated and tends to increase with disease progression. 7 The present study shows that the most powerful modulator of the association between TR and clinical outcome was PASP, and that PHassociated FTR portends a higher risk for readmission for HF and mortality. The present study demonstrates the inextricable link between TR severity, RV function, and PH. PASP and RV dysfunction were two key factors strongly associated with moderate or severe TR ( Table  2) . Most patients with moderate or severe TR had PH, and RV dysfunction was present in 31% and 55% of patients with moderate and severe TR, respectively. However, RV dysfunction was not independently associated with readmission for HF or mortality. Collectively, these data suggest that the RV volume overload alone induced by TR may be insufficient to meaningfully alter the clinical outcome. However, when volume overload is superimposed on preexisting pressure overload, the risk for readmission for HF and mortality increases. These data reinforce the key role of PH in the pathophysiology and progression of TR in patients with HF. 7 Beyond its association with cardiac abnormalities, TR was also associated with reduced renal function, greater congestion, and higher BNP levels. The association between haemodynamically significant TR and renal dysfunction has been ascribed to higher central and renal venous pressure, leading to reduced renal perfusion pressure. 22 
Clinical implications
FTR frequently accompanies advanced stage of HF, regardless of aetiology, 2 and progression to significant TR in contemporary patients is frequently not related to left-sided valvular disease. 7 Therefore, an Figure 4 the Kaplan-Meier survival plot of mortality or readmission for heart failure in subgroups defined by pulmonary hypertension and TR severity (log-rank test P < 0.0001). HF, heart failure; PH, pulmonary hypertension; TR, tricuspid regurgitation. appropriate interpretation of the clinical significance of FTR in the context of patients with symptomatic HF is warranted. In the absence of other indications for cardiac surgery, current guideline consider patient with severe TR and congestive signs directly related to the TR and progressive RV dysfunction as candidates for surgery. 8, 20 Recent previous studies suggest that severe isolated TR adversely affects clinical outcome, 17 and that TV replacement may be beneficial when performed in patients with mild or no HF. 23 However, as shown in the present study, it would be difficult to view severe TR as the predominant culprit of adverse clinical outcome in the majority of patients with overt HF and fluid overload. The TR-specific impact on outcome is difficult to extricate but was not significant in the present study.
Study limitations
This study has limitations that need be acknowledged. The study is a single-centre study. TR severity was not assessed using quantitative methods. Quantitative methods for TR estimation have their limitations and are not widely practiced. 3 As in previous studies, 1,2,5-7 using a semiquantitative approach, we were able to define groups with distinct clinical presentation and echocardiographic parameters that attest to the validity of our methods. Because of the bidirectional link between congestion and TR, fluid overload secondary to worsening HF may lead to overestimation of the true TR severity.
Conclusion
Patients presenting with HF and significant FTR have multiple coexisting cardiac abnormalities. The impact of FTR on the clinical outcome in HF patients depends on the severity of PH. In patient with symptomatic HF, FTR provides no additive risk in the presence of normal or mildly elevated pulmonary pressures. However, it is associated with excess rehospitalizations and mortality in patients with PH.
